- Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…BioPharma Dive · 26d ago↗ source
- Republican Tom Kean Jr. reveals depression diagnosis after his four-month absence from CongressDepression, the New Jersey congressman said, “is physical, it is emotional, and until you experience it yourself, it is difficult to fully understand how powerful this illness can be.”STAT · 26d ago↗ source
- FDA reviewers oppose allowing seven peptides for compoundingAhead of an FDA advisory committee meeting to discuss lifting restrictions on seven popular peptides, agency reviewers have recommended against including the peptides on a list of bulk drug substan…